ArticleKidney3602026
Shared T -Cell Receptor Repertoire in the Tonsils of Patients with IgA Nephropathy.
Article in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- IgA Nephropathy: Mechanisms, Risk Stratification, and Precision Therapy.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
key pointsPatients with IgA nephropathy have significantly more abundant and shared joining regions in TCR α repertoires compared with those with recurrent tonsillitis. These are characterized by shorter complementary determining region 3 lengths and low mucosal-associated invariant T match scores. The clonotypes are correlated with the IgA-binding index of bacteroidetes and with tonsillar galactose-deficient IgA1 in these patients.
backgroundAberrant mucosal immune responses are underlying causes of IgA nephropathy (IgAN), the most prevalent type of chronic GN. However, the role of T cells in IgA nephropathy pathogenesis remains elusive. To address this knowledge gap, we profiled the T -cell receptor repertoire in the tonsils of patients with IgA nephropathy.
methodsThis study included 27 and 20 patients with biopsy-confirmed IgA nephropathy and recurrent tonsillitis (RT), respectively, who underwent tonsillectomy. The T -cell receptor (TCR) repertoire was determined by high-throughput sequencing coupled with unbiased adaptor ligation PCR. Furthermore, the usage of variable and joining regions in TCR α (TRA) and joining regions in TCR β (TRB) genes in each group was assessed. TRA clonotypes shared among the patients were characterized by complementary determining region 3 lengths, types of mucosal-associated invariant T (MAIT) cells, hydrophobicity, and their relationships with tonsillar galactose-deficient IgA1 and tonsillar IgA-binding indices of tonsillar bacteria.
resultsThe TRA repertoire exhibited significantly lower similarity in patients with IgA nephropathy than did in RT cases ( P < 0.001). Sharing TRA clonotypes among patients with IgA nephropathy was significantly sparser than that among RT cases. The relative abundance of shared TRA clonotypes with shorter complementary determining region 3 lengths was significantly increased in patients with IgA nephropathy ( P_adj = 0.041), which was characterized by low MAIT match scores. Significant negative correlations were observed between the MAIT scores and hydrophobicity for these TRA clonotypes in patients with IgA nephropathy. The relative abundances of these clonotypes significantly and positively correlated with the IgA binding indices of the phylum Bacteroidetes ( P_adj = 0.008) in both groups and tonsillar galactose-deficient IgA1 levels in patients with IgA nephropathy ( P = 0.035).
conclusionsThe results in this study suggest aberrant T -cell subsets involvement in tonsillar immunity in patients with IgA nephropathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.